Solved

-Prime Pharmaceuticals Has Developed a New Asthma Medicine, for Which

Question 95

Multiple Choice

-Prime Pharmaceuticals has developed a new asthma medicine, for which it has a patent. An inhaler can be produced at a constant marginal cost of $2/inhaler. The demand curve, marginal revenue curve, and marginal cost curve for this new asthma inhaler are in the figure above. With its patent giving it a monopoly for its new inhaler, if Prime Pharmaceuticals operates as a single- price monopoly, then there will be a deadweight loss equal to A) $24 million. B) $16 million. C) zero. D) $32 million.
-Prime Pharmaceuticals has developed a new asthma medicine, for which it has a patent. An inhaler can be produced at a constant marginal cost of $2/inhaler. The demand curve, marginal revenue curve, and marginal cost curve for this new asthma inhaler are in the figure above. With its patent giving it a monopoly for its new inhaler, if Prime Pharmaceuticals operates as a single- price monopoly, then there will be a deadweight loss equal to


A) $24 million.
B) $16 million.
C) zero.
D) $32 million.

Correct Answer:

verifed

Verified

Unlock this answer now
Get Access to more Verified Answers free of charge

Related Questions

Q90: A monopoly is BEST defined as a

Q91: -The table above</p></div><svg width=

Q92: -The figure above</p></div><svg width=

Q93: Patents encourage inventions because without a patent
A)

Q94: A price cap regulation _ .
A) is

Q96: Which of the following is true about

Q97: -Prime Pharmaceuticals has</p></div><svg width=

Q98: Which of the following is necessary for

Q99: The social interest theory of regulation assumes

Q100: A single- price monopolist produces a _

Unlock this Answer For Free Now!

View this answer and more for free by performing one of the following actions

qr-code

Scan the QR code to install the App and get 2 free unlocks

upload documents

Unlock quizzes for free by uploading documents